Omnicell OMCL
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 35th percentile, 5-year average 69.7x
#2351 of 2994 stocks by PE (1 = cheapest)
Below its usual level · 23rd percentile, 5-year average 2.2x
#1833 of 5336 stocks by PB (1 = cheapest)
Below its usual level · 24th percentile, 5-year average 2.2x
#1984 of 5159 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.22 | – | 2.23 | 23% (cheaper than usual) | #1833 of 5336 (1 = cheapest) |
| PE | 36.49 | 36.52 | 69.74 | 35% (cheaper than usual) | #2351 of 2994 (1 = cheapest) |
| PS | 1.30 | 1.32 | 2.21 | 24% (cheaper than usual) | #1984 of 5159 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on OMCL.
Sign in to join the discussion.